Topic Hub
110 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 110 of 110 clinical reviews.
Evidence-based guide to pioglitazone (Actos) drug-drug interactions, covering CYP2C8 inhibitors, insulin co-administration, heart failure risk multipliers, and clinical management strategies.
Read clinical reviewCurrent pioglitazone pricing in Alaska for 2026, including cash-pay costs, Alaska Medicaid coverage status, insurance options, discount programs, and telehealth access.
Read clinical reviewWhat pioglitazone costs in Arizona in 2026, including cash prices, Medicaid coverage, insurance options, discount programs, and compounded alternatives at 503A pharmacies.
Read clinical reviewCurrent pioglitazone pricing in California for 2026, including generic cash-pay costs, Medi-Cal coverage details, 503A compounding options, telehealth access, and discount programs.
Read clinical reviewCurrent 2026 prices for Actos (pioglitazone) in Colorado. Compare retail, generic, Medicaid, insurance, and discount program costs across CO pharmacies.
Read clinical reviewWhat Actos (pioglitazone) costs in Delaware in 2026, including cash prices, Medicaid coverage, insurance options, discount programs, and compounded alternatives.
Read clinical reviewCurrent 2026 prices for Actos (pioglitazone) in District of Columbia. Covers cash-pay costs, Medicaid coverage with prior authorization, insurance options, discount programs, compounded pioglitazone, and telehealth access in DC.
Read clinical reviewCurrent 2026 pioglitazone prices in Florida, including cash-pay, Medicaid, insurance coverage, compounding options, telehealth access, and discount programs.
Read clinical reviewCurrent 2026 pricing for Actos (pioglitazone) in Georgia, including generic cash-pay costs, Medicaid coverage details, insurance tiers, compounding pharmacy options, and discount programs.
Read clinical reviewCurrent pioglitazone prices in Hawaii for 2026, including cash-pay costs, Medicaid coverage status, insurance options, telehealth access, and discount programs.
Read clinical reviewWhat Actos (pioglitazone) costs in Illinois in 2026, including cash prices, Medicaid coverage, insurance tiers, discount programs, and compounded options at 503A pharmacies.
Read clinical reviewCurrent pioglitazone prices in Indiana for 2026, including cash-pay costs, Medicaid coverage details, insurance options, discount programs, and compounding pharmacy availability.
Read clinical reviewWhat pioglitazone costs in Iowa in 2026. Cash prices, Iowa Medicaid coverage status, insurance options, 503A compounding, telehealth access, and discount programs explained.
Read clinical reviewComplete guide to pioglitazone (Actos) pricing in Kansas for 2026, including cash-pay costs, Medicaid coverage, insurance options, telehealth access, and discount programs.
Read clinical reviewCurrent 2026 pricing for Actos (pioglitazone) in Kentucky. Covers cash-pay costs, Medicaid coverage status, insurance tiers, 503A compounding, telehealth access, and discount programs.
Read clinical reviewCurrent 2026 pricing for Actos (pioglitazone) in Louisiana. Cash-pay averages, Medicaid status, insurance tiers, discount programs, compounding options, and telehealth access.
Read clinical reviewWhat Actos (pioglitazone) costs in Maine in 2026, including cash prices, Medicaid coverage, insurance tiers, discount programs, compounding options, and telehealth access.
Read clinical reviewCurrent pioglitazone prices in Maryland for 2026, including cash-pay costs, Medicaid coverage, insurance options, discount programs, and the cheapest ways to fill your prescription.
Read clinical reviewCurrent 2026 prices for Actos (pioglitazone) in Massachusetts. Covers cash-pay, Medicaid, insurance, compounded options, discount programs, and telehealth access across the state.
Read clinical reviewCurrent 2026 prices for Actos (pioglitazone) in Michigan, including cash-pay, Medicaid coverage, insurance options, discount programs, and compounded alternatives.
Read clinical reviewCurrent 2026 prices for Actos (pioglitazone) in Minnesota. Generic costs as low as $15/month cash-pay, Medicaid coverage with PA, telehealth options, and discount programs.
Read clinical reviewCurrent 2026 prices for Actos (pioglitazone) in Mississippi. Covers cash-pay costs, Medicaid status, insurance tiers, generic savings, telehealth access, and discount programs across MS pharmacies.
Read clinical reviewWhat Actos (pioglitazone) costs in Missouri in 2026. Cash prices, Medicaid coverage, insurance tiers, discount programs, compounding options, and telehealth access across MO pharmacies.
Read clinical reviewWhat pioglitazone costs in Montana in 2026, including cash prices, Medicaid status, insurance tiers, discount programs, and telehealth access across MT pharmacies.
Read clinical reviewCurrent 2026 pricing for Actos (pioglitazone) in New Hampshire. Covers cash-pay costs, Medicaid status, insurance coverage, discount programs, telehealth access, and compounding options.
Read clinical reviewComplete guide to Actos (pioglitazone) pricing in New Jersey for 2026, including Medicaid coverage, insurance options, discount programs, telehealth access, and compounded alternatives.
Read clinical reviewWhat Actos (pioglitazone) costs in North Carolina in 2026, including cash prices, Medicaid coverage, insurance tiers, compounding options, and discount programs.
Read clinical reviewWhat pioglitazone costs in Oregon in 2026, including Medicaid coverage, insurance copays, generic pricing, discount programs, and compounded options at 503A pharmacies.
Read clinical reviewFind out how much Actos (pioglitazone) costs in Pennsylvania in 2026. Covers cash prices, Medicaid coverage, insurance options, discount programs, and telehealth access across PA pharmacies.
Read clinical reviewCurrent 2026 prices for Actos (pioglitazone) in South Dakota. Covers cash-pay costs, Medicaid coverage status, insurance options, discount programs, telehealth access, and compounding pharmacy legality.
Read clinical reviewWhat Actos (pioglitazone) costs in Texas in 2026, including cash-pay pricing, Medicaid coverage, insurance tiers, 503A compounding options, telehealth access, and discount programs.
Read clinical reviewCurrent pioglitazone prices in Vermont for 2026, including Medicaid coverage, insurance copays, generic and compounded options, discount programs, and telehealth access.
Read clinical reviewCurrent pioglitazone prices in Virginia for 2026, including cash-pay costs, Medicaid coverage, insurance options, discount programs, and compounded alternatives.
Read clinical reviewWhat Actos (pioglitazone) costs in Wyoming in 2026, including cash prices, Medicaid coverage, insurance options, discount programs, and how to get the lowest price at Wyoming pharmacies.
Read clinical reviewCompare pioglitazone (Actos) pricing against metformin, rosiglitazone, SGLT2 inhibitors, and GLP-1 receptor agonists. Includes mechanism of action, NASH data from PIVENS, and insurance guidance.
Read clinical reviewHow to dose pioglitazone (Actos) for adults aged 50-64, including starting doses, titration schedules, cardiovascular considerations, and NASH off-label use backed by clinical trial data.
Read clinical reviewComplete guide to pioglitazone (Actos) dosing in young adults aged 18 to 29, covering starting doses, titration, NASH off-label use, fertility considerations, and monitoring protocols.
Read clinical reviewEvidence-based guide to pioglitazone use in patients with liver disease. Covers FDA labeling, ALT thresholds, PIVENS trial data in NASH, monitoring protocols, and dose adjustment recommendations.
Read clinical reviewEvidence-based guide to pioglitazone dosing in patients with chronic kidney disease. No dose adjustment is required, but fluid retention risks demand careful monitoring.
Read clinical reviewEvidence-based guide to pioglitazone (Actos) interactions with foods, supplements, and herbal products. Includes CYP2C8 pathway details, grapefruit data, and clinical recommendations.
Read clinical reviewA clinician-reviewed guide to using pioglitazone (Actos) for metabolic syndrome: trial evidence, off-label dosing, side-effect management, and who qualifies for treatment.
Read clinical reviewA clinician-reviewed guide to pioglitazone (Actos) for NAFLD and MASLD: PIVENS trial data, dosing protocols, side-effect management, and how it compares to newer agents like resmetirom and semaglutide.
Read clinical reviewA clinician-reviewed guide to using pioglitazone (Actos) off-label for prediabetes, covering the ACT NOW trial, dosing protocols, side effects, and insurance considerations.
Read clinical reviewComplete clinical guide to pioglitazone (Actos) for type 2 diabetes: FDA approval, dosing, trial evidence, side effects, and how it compares to metformin, GLP-1s, and SGLT2 inhibitors.
Read clinical reviewEvidence-based guide to pioglitazone dosing in adults 65 and older, covering starting doses, fracture risk, heart failure screening, renal considerations, and deprescribing.
Read clinical reviewEvidence-based guide to pioglitazone safety in adults 65 and older, covering fracture risk, heart failure, edema, bladder cancer concerns, drug interactions, and deprescribing strategies.
Read clinical reviewA detailed look at pioglitazone's manufacturing timeline, generic market evolution, FDA shortage records, and current supply status for this thiazolidinedione used in type 2 diabetes and off-label NASH.
Read clinical reviewA physician-level deep dive into how pioglitazone works, from PPARγ receptor activation and adiponectin upregulation to insulin sensitization, hepatic fat reduction, and anti-inflammatory signaling.
Read clinical reviewWhat to do when you miss a dose of pioglitazone (Actos). Evidence-based guidance on timing, pharmacokinetics, and when to skip vs. take your missed dose.
Read clinical reviewEvidence-based monitoring guide for pioglitazone (Actos) in adults aged 30, 49. Covers liver function tests, weight tracking, cardiac screening, bone density, and NASH-specific follow-up with clinical timelines.
Read clinical reviewA clinician-reviewed guide to monitoring pioglitazone (Actos) in adults aged 50 to 64, covering liver enzymes, heart failure screening, bone density, bladder surveillance, and polypharmacy checks.
Read clinical reviewEvidence-based monitoring guide for young adults aged 18 to 29 taking pioglitazone (Actos) for type 2 diabetes or NASH. Covers liver function tests, weight tracking, bone density, fertility considerations, and lab schedules.
Read clinical reviewA clinical review of pioglitazone's off-label applications including NASH/MASLD, stroke prevention, PCOS, and lipodystrophy, with trial data, dosing, and evidence grades.
Read clinical reviewEvidence-based monitoring protocols for pioglitazone (Actos) use in children under 12, covering liver function, weight, bone density, and growth tracking with clinical guidance.
Read clinical reviewPioglitazone (Actos) is not FDA-approved for children under 12. This evidence-based review covers pediatric safety data, off-label NASH considerations, weight gain risks, bone density concerns, and monitoring protocols for young patients.
Read clinical reviewHow CYP2C8, PPARG, and other gene variants alter pioglitazone metabolism, efficacy, and side-effect risk. Evidence-based pharmacogenomic guidance for clinicians and patients.
Read clinical reviewA physician-level review of pioglitazone (Actos) pharmacokinetics covering oral absorption, protein binding, CYP-mediated metabolism, active metabolites M-III and M-IV, and renal/fecal elimination with PubMed-cited evidence.
Read clinical reviewEvidence-based review of pioglitazone (Actos) safety during pregnancy and breastfeeding, including FDA labeling, animal data, clinical alternatives, and lactation pharmacokinetics.
Read clinical reviewA physician-level review of pioglitazone (Actos) real-world evidence from registries, claims databases, and observational cohorts covering cardiovascular outcomes, NASH/MASLD resolution, and long-term safety.
Read clinical reviewEvidence-based guide to pioglitazone (Actos) safety for adults aged 50 to 64, covering cardiovascular outcomes, fracture risk, bladder cancer concerns, NASH data, and monitoring protocols.
Read clinical reviewShowing the first 60 matches. Use search or filters to narrow the library.